Cargando…

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis

BACKGROUND: The World Health Organization Model List of Essential Medicines (WHO EML) has played a critical role in guiding the country-level selection and financing of medicines for more than 4 decades. It continues to be a relevant evidence-based policy that can support universal health coverage (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peacocke, Elizabeth F., Myhre, Sonja L., Foss, Hakan Safaralilo, Gopinathan, Unni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956172/ https://www.ncbi.nlm.nih.gov/pubmed/35275938 http://dx.doi.org/10.1371/journal.pmed.1003944

Ejemplares similares

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Monographs for medicines on WHO’s Model List of Essential Medicines
por: Roth, Lukas, et al.
Publicado: (2018)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
por: Jeličić Kadić, Antonia, et al.
Publicado: (2014)

Biologic medicine inclusion in 138 national essential medicines lists
por: Kraus, Raphaël, et al.
Publicado: (2021)

National List of Essential Medicines, 2015: Endocrinology perspective
por: Kalra, Sanjay
Publicado: (2016)

A comparison of national essential medicines lists in the Americas
por: Steiner, Liane, et al.
Publicado: (2020)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

Essential tuberculosis medicines and health outcomes in countries with a national essential medicines list
por: Maraj, Darshanand, et al.
Publicado: (2022)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

R&D for Emerging Infectious Diseases of Epidemic Potential: Sharing Risks and Benefits Through a New Coalition
por: Gopinathan, Unni, et al.
Publicado: (2020)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Communication around HPV vaccination for adolescents in low- and middle-income countries: a systematic scoping overview of systematic reviews
por: Foss, Hakan Safaralilo, et al.
Publicado: (2019)

Challenges in updating national guidelines and essential medicines lists in Sub‐Saharan African countries to include WHO‐recommended postpartum hemorrhage medicines
por: Ng'ang'a, Joyce, et al.
Publicado: (2022)

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020)

A critical look at the national essential medicines list of India 2003
por: Manikandan, S
Publicado: (2010)

The national essential medicines list of India: Time to revise and purge the mistakes
por: Gitanjali, B
Publicado: (2010)

National List of Essential Medicines 2022 of India: Perspectives from Psychiatrists
por: Parmar, Arpit, et al.
Publicado: (2023)

Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study
por: Tauqeer, Fatima, et al.
Publicado: (2019)

Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members
por: Perumal-Pillay, Velisha Ann, et al.
Publicado: (2017)

WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?
por: Rowlands, Amanda, et al.
Publicado: (2016)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
por: Cappello, Bernadette, et al.
Publicado: (2020)

Priority Medicines for Maternal and Child Health: A Global Survey of National Essential Medicines Lists
por: Hill, Suzanne, et al.
Publicado: (2012)

Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
por: Baldeh, Ayo-Oley, et al.
Publicado: (2023)

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders
por: Jarvis, Jordan D., et al.
Publicado: (2019)

How can WHO transform its approach to social determinants of health?
por: Gopinathan, Unni, et al.
Publicado: (2022)

A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
por: Naicker, Ian, et al.
Publicado: (2022)

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
por: Zhou, Yue, et al.
Publicado: (2023)

Essential medicines for cancer: WHO recommendations and national priorities
por: Robertson, Jane, et al.
Publicado: (2016)

Relation between opioid consumption and inclusion of opioids in 137 national essential medicines lists
por: Richards, Georgia C, et al.
Publicado: (2020)

The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line
por: Manikandan, S.
Publicado: (2023)

Chinese Proprietary Herbal Medicine Listed in ‘China National Essential Drug List’ for Common Cold: A Systematic Literature Review
por: Chen, Wei, et al.
Publicado: (2014)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

The case for levetiracetam to be included in essential medicine lists
por: Singh, Gagandeep, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dmvbv3glrpn6sseq9joo6e8dfj